The Gross Margin of Innate Pharma SA (IPH.PA) is 94.50%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 94.50% |
| 2023-12-31 | 94.50% |
| 2022-12-31 | 92.78% |
| 2021-12-31 | 74.69% |
| 2020-12-31 | 93.61% |
| 2019-12-31 | 95.35% |
| 2018-12-31 | 95.22% |
| 2017-12-31 | 86.86% |
| 2016-12-31 | 94.92% |
| 2015-12-31 | 85.44% |